HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kuniaki Seyama Selected Research

Birt-Hogg-Dube Syndrome

4/2020Quantitative Analysis of Cystic Lung Diseases by Use of Paired Inspiratory and Expiratory CT: Estimation of the Extent of Cyst-Airway Communication and Evaluation of Diagnostic Utility.
4/2020A case of Birt-Hogg-Dubé syndrome implying reduced or no wild-type folliculin without mutated protein is pathogenic.
1/2018A total pleural covering of absorbable cellulose mesh prevents pneumothorax recurrence in patients with Birt-Hogg-Dubé syndrome.
1/2017Difference of the progression of pulmonary cysts assessed by computed tomography among COPD, lymphangioleiomyomatosis, and Birt-Hogg-Dubé syndrome.
10/2016[A Case of Birt-Hogg-Dubé Syndrome, Lung Cyst was Reduced by Inhalation of a Long-acting Anticholinergic Agent].
6/2012Differentiation between Birt-Hogg-Dubé syndrome and lymphangioleiomyomatosis: quantitative analysis of pulmonary cysts on computed tomography of the chest in 66 females.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kuniaki Seyama Research Topics

Disease

50Lymphangioleiomyomatosis (Lymphangiomyomatosis)
02/2022 - 01/2002
16Lung Diseases (Lung Disease)
01/2021 - 01/2002
14Neoplasms (Cancer)
12/2020 - 01/2002
12Pneumothorax
01/2022 - 12/2005
12Chronic Obstructive Pulmonary Disease (COPD)
11/2018 - 12/2003
11Cysts
01/2021 - 06/2012
10Tuberous Sclerosis (Bourneville's Disease)
01/2021 - 01/2002
6Birt-Hogg-Dube Syndrome
04/2020 - 06/2012
5Respiratory Insufficiency (Respiratory Failure)
02/2022 - 12/2005
5Dyspnea (Shortness of Breath)
02/2022 - 08/2008
5Pulmonary Emphysema
01/2022 - 09/2006
5Emphysema
01/2019 - 02/2006
5Pleural Effusion (Pleural Effusions)
10/2018 - 10/2005
4Chylothorax
10/2018 - 08/2008
4Inflammation (Inflammations)
10/2017 - 12/2003
4Disease Progression
01/2017 - 01/2006
3Lung Neoplasms (Lung Cancer)
02/2022 - 01/2009
3Rare Diseases (Rare Disease)
01/2019 - 03/2010
3Hyperplasia
01/2019 - 09/2010
3Pneumonia (Pneumonitis)
11/2016 - 07/2006
3Hypoxia (Hypoxemia)
04/2016 - 11/2012
3Fibrosis (Cirrhosis)
10/2013 - 11/2004
3Angiomyolipoma
09/2013 - 10/2005
3Neoplasm Metastasis (Metastasis)
10/2009 - 01/2006
2COVID-19
01/2022 - 01/2022
2Lymphadenopathy
12/2020 - 03/2015
2Asthma (Bronchial Asthma)
11/2017 - 12/2015
2Lymphangiomyoma
01/2017 - 04/2010
2Lymphatic Abnormalities
03/2015 - 10/2005
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2012 - 12/2008
2Carcinoma (Carcinomatosis)
01/2012 - 10/2009
2Cachexia
01/2012 - 01/2008
2Adenocarcinoma
01/2012 - 12/2008
2Chylous Ascites
01/2010 - 01/2008
2Ascites
01/2008 - 10/2005
1Asymptomatic Infections
01/2022
1Weight Gain
01/2022
1Anemia
12/2020
1Splenomegaly
12/2020
1Carcinogenesis
04/2020
1Renal Cell Carcinoma (Grawitz Tumor)
04/2020
1Liver Diseases (Liver Disease)
01/2018
1Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome
11/2017
1Obstructive Lung Diseases (Obstructive Lung Disease)
11/2017
1Stomatitis
10/2017
1Pulmonary Atelectasis
06/2016
1Blister (Bulla)
06/2016

Drug/Important Bio-Agent (IBA)

47lipoarabinomannan (LAM)IBA
02/2022 - 01/2002
11trans-sodium crocetinate (crocetin)IBA
01/2021 - 01/2002
9Sirolimus (Rapamycin)FDA Link
02/2020 - 08/2008
8SmokeIBA
01/2022 - 02/2006
6Proteins (Proteins, Gene)FDA Link
12/2020 - 11/2004
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2016 - 02/2008
3Vascular Endothelial Growth Factor DIBA
01/2020 - 01/2006
3Ascorbic Acid (Vitamin C)FDA LinkGeneric
11/2017 - 06/2010
3Pharmaceutical PreparationsIBA
10/2017 - 01/2009
3TOR Serine-Threonine KinasesIBA
11/2015 - 12/2011
3tulobuterolIBA
04/2015 - 01/2005
3CytokinesIBA
10/2013 - 10/2009
3Prednisolone (Predate)FDA LinkGeneric
10/2009 - 08/2008
2ErbB Receptors (EGF Receptor)IBA
11/2018 - 11/2012
2AntioxidantsIBA
11/2017 - 10/2017
2LycopeneIBA
11/2017 - 02/2006
2Biomarkers (Surrogate Marker)IBA
12/2015 - 01/2006
2Interleukin-6 (Interleukin 6)IBA
10/2013 - 01/2012
2Gefitinib (Iressa)FDA Link
11/2012 - 12/2008
2Bronchodilator Agents (Bronchodilators)IBA
02/2010 - 01/2005
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2009 - 01/2009
1BNT162 VaccineIBA
01/2022
1AerosolsIBA
01/2022
1AntibodiesIBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2020
1clonidine-displacing substance (ClDS)IBA
04/2020
1purified rayonIBA
04/2018
1CelluloseIBA
04/2018
1Oxidized CelluloseIBA
01/2018
1Mutant Proteins (Protein, Mutant)IBA
01/2018
1Glutathione Disulfide (GSSG)FDA LinkGeneric
11/2017
1Vitamin A (Retinol)FDA LinkGeneric
11/2017
1Vitamin EFDA LinkGeneric
11/2017
1Carotenoids (Carotene)IBA
11/2017
1Tocopherols (Tocopherol)IBA
11/2017
1HydrogenIBA
10/2017
1Hydroxyl RadicalIBA
10/2017
1Oxidants (Oxidizing Agents)IBA
10/2017
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2017
1Microphthalmia-Associated Transcription FactorIBA
11/2016
1Cholinergic Antagonists (Anticholinergics)IBA
10/2016
1Oxygen (Dioxygen)IBA
06/2016
1Mechanistic Target of Rapamycin Complex 1IBA
04/2016

Therapy/Procedure

6Pleurodesis
01/2022 - 01/2009
6Lung Transplantation
10/2018 - 08/2008
5Therapeutics
01/2019 - 11/2015
2Drug Therapy (Chemotherapy)
01/2009 - 01/2004
1Operative Surgical Procedures
01/2022
1Nephrectomy
04/2020
1Chest Tubes (Chest Tube)
10/2018
1Tonsillectomy
11/2016
1Ligation
06/2016